Citation: | Zheng MIAO, Jia-ming QIAN, Jing-nan LI, Xiao-yan TANG, Xiao-ou YANG. Establishment of Two Murine Models of Ulcerative Colitis and Comparison of the Mechanism of Colitis-related Inflammatory Reactions[J]. Medical Journal of Peking Union Medical College Hospital, 2010, 1(2): 145-149. |
[1] |
Abraham C, Cho JH.Inflammatory bowel disease[J]. New Engl J Med, 2009, 361:2066-2078. DOI: 10.1056/NEJMra0804647
|
[2] |
Melgar S, Karlsson A, Michaelsson E.Acute colitis induced by dextran sulphate sodium progresses into chronicity in C57BL/6 but not in BALB/c mice-correlation between symptoms and inflammation[J]. Am J Physiol Gastrointest Liver Physiol, 2005, 288:G1328-G1338. DOI: 10.1152/ajpgi.00467.2004
|
[3] |
Heller F, Fuss IJ, Nieuwenhuis EE, et al.Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13 -producing NK-T cells[J]. Immunity, 2002, 17:629-638. DOI: 10.1016/S1074-7613(02)00453-3
|
[4] |
Okayasu I, Hatakeyama S, Yamada M, et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice[J]. Gastroenterology, 1990, 98:694-702. DOI: 10.1016/0016-5085(90)90290-H
|
[5] |
Luk HH, Ko JK, Fung HS, et al.Delineation of the protective action of zinc sulfate on ulcerative colitis in rats[J]. Eur J Pharmacol, 2002, 443:197-204. DOI: 10.1016/S0014-2999(02)01592-3
|
[6] |
Ekstrom GM.Oxazolone-induced colitis in rats:effects of budesonide, cyclosporin A, and 5-aminosalicylic acid[J]. Scand J Gastroenterol, 1998, 33:174-179. DOI: 10.1080/00365529850166914
|
[7] |
Fausto SM, Aaron DL, Jesus KY.Role of cytokines in inflammatory bowel disease[J]. World Gastroenterol, 2008, 14:4280-4288. DOI: 10.3748/wjg.14.4280
|
[8] |
Forbes E, Murase T, Yang M, et al.Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase[J]. J Immunol, 2004, 172:5664-5675. DOI: 10.4049/jimmunol.172.9.5664
|
[9] |
Choi SY, Hur SJ, An CS, et al.Anti-inflammatory effects of Inonotus obliquus in colitis induced by dextran sodium sulfate [J]. Biomed Biotechnol, 2010-03-10 [Epub ahead of print]. http://www.hindawi.com/journals/jbb/.
|
[10] |
Ryotaro K, Satoko K, Tomiko O, et al.Oxazolone-induced Colitis in BALB/C mice:a new method to evaluate the efficacy of therapeutic agents for ulcerative Colitis[J]. Pharmacol Sci, 2004, 96:307-313. DOI: 10.1254/jphs.FP0040214
|
[11] |
Dharmani P, Chadee K.Biologic therapies against inflammatory bowel disease:a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key[J]. Curr Mol Pharmacol, 2008, 1:195-212. DOI: 10.2174/1874467210801030195
|
[12] |
David QS, Stephan RT.Immunopathogenesis of inflammatory bowel disease[J]. World J Gastroenterol, 2008, 14: 390-400. http://doi.med.wanfangdata.com.cn/qk/wjg200803007
|
[13] |
Neurath MF, Finotto S, Glimcher LH.The role of Th1/Th2 polarization in mucosal immunity[J]. Nat Med, 2002, 8: 567-573 DOI: 10.1038/nm0602-567
|
1. |
梁桂丽,李灿美,邢成锋,董运龙,王娟,雷梓,缪应雷,兰丹凤. GC-C~(-/-)小鼠在DSS诱导下肠道炎症损伤的变化. 昆明医科大学学报. 2022(07): 1-8 .
![]() | |
2. |
孔红梅,程毅东. 复方谷氨酰胺联合益生菌对活动期溃疡性结肠炎肠道屏障功能及细胞因子的影响. 实用临床医药杂志. 2014(13): 29-32 .
![]() |